India’s pharmaceutical strategy shifts from scale to innovation to position it as hub for biopharma and high-value therapeutics
In the global pharmaceutical landscape, biologics, biosimilars and specialty drugs now account f...
In the global pharmaceutical landscape, biologics, biosimilars and specialty drugs now account f...